| Metric | FY 2026↕ | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.2B | $6.1B | $5.5B | $5.0B | $4.4B | $1.0B | $0.9B | $0.7B |
| Cost of Revenue | $0.7B | $0.6B | $0.5B | $0.5B | $0.4B | $0.3B | $0.3B | $0.3B |
| Gross Profit | $6.6B | $5.6B | $5.0B | $4.5B | $4.0B | $0.9B | $0.8B | $0.7B |
| R&D Expense | $1.6B | $1.5B | $1.4B | $1.2B | $1.1B | $0.9B | $0.9B | $0.7B |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $1.6B | $1.4B | $1.1B | $1.0B | $0.6B | $0.2B | $0.1B | $0.0B |
| Net Income | $1.1B | $1.1B | $0.9B | $0.8B | $0.5B | $0.9B | $0.1B | $0.1B |
| EPS (Basic) | $5.28 | $5.17 | $4.23 | $3.81 | $2.26 | $4.15 | $0.60 | $0.30 |
| EPS (Diluted) | $5.23 | $5.12 | $4.19 | $3.78 | $2.24 | $4.10 | $0.59 | $0.29 |
| Metric | FY 2026↕ | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $12.5B | $10.8B | $9.9B | $9.4B | $8.6B | $7.3B | $6.2B | $4.7B |
| Current Assets | $4.9B | $3.5B | $3.6B | $3.3B | $2.8B | $2.7B | $2.7B | $1.6B |
| Cash & Equivalents | $2.2B | $1.6B | $1.9B | $1.9B | $1.5B | $1.8B | $1.8B | $0.9B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $5.8B | $5.2B | $4.4B | $4.0B | $4.0B | $3.3B | $3.2B | $2.3B |
| Stockholders' Equity | $3.0B | $2.6B | $1.9B | $1.1B | $0.8B | $1.0B | $-0.1B | $-0.2B |
| Metric | FY 2026↕ | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.5B | $1.6B | $1.3B | $2.1B | $1.5B | $1.4B | $1.4B | $0.4B |
| Investing Cash Flow | $-0.5B | $-0.9B | $-0.5B | $-0.1B | $-1.6B | $-0.4B | $-0.1B | $-0.7B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.1B | $0.1B | — | — |
| Financing Cash Flow | $-1.4B | $-1.0B | $-0.9B | $-1.5B | $-0.2B | $-1.0B | $-0.5B | $0.2B |